2010
DOI: 10.1111/j.1600-0625.2009.01036.x
|View full text |Cite
|
Sign up to set email alerts
|

Zeaxanthin inhibits PDGF‐BB‐induced migration in human dermal fibroblasts

Abstract: Zeaxanthin is the dihydroxy carotenoid and is distributed in our daily foods. Various natural carotenoids, including zeaxanthin, have been shown to inhibit proliferation of several types of cancer cells, but available data on the effect of zeaxanthin on skin fibroblasts and melanoma cells are limited. Platelet-derived growth factor (PDGF) functions as a chemotactic factor for dermal fibroblasts and plays an important role in the progression of melanoma. In this study, we investigated the effects of zeaxanthin … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
28
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(28 citation statements)
references
References 37 publications
0
28
0
Order By: Relevance
“…There is a report that zeaxanthin can inhibit PDGF-BB-induced migration in human dermal fibroblasts. The authors concluded that zeaxanthin affects cellular components but does not directly interact with PDGF-BB [34]. In our system, zeaxanthin was found to inhibit PDGF-BB-induced PDGFR and PLCγ activation; however surprisingly it only marginally affected Akt, ERK1/2, and p38 MAPK activation (Figure 8).…”
Section: Discussionmentioning
confidence: 52%
“…There is a report that zeaxanthin can inhibit PDGF-BB-induced migration in human dermal fibroblasts. The authors concluded that zeaxanthin affects cellular components but does not directly interact with PDGF-BB [34]. In our system, zeaxanthin was found to inhibit PDGF-BB-induced PDGFR and PLCγ activation; however surprisingly it only marginally affected Akt, ERK1/2, and p38 MAPK activation (Figure 8).…”
Section: Discussionmentioning
confidence: 52%
“…In order to know if the antiproliferative activity of F4 was due to the presence of zeaxanthin, the antiproliferative activity of standard zeaxanthin (Sigma-Aldrich, Saint-Quentin Fallavier, France) was studied in A-2058 melanoma cells. This study revealed that 100 µg·mL −1 zeaxanthin induced 38.4% ± 4.2% growth inhibition at 72 h ( n = 4, p = 0.0245, statistically significant in the t test ), demonstrating for the first time the antimelanoma activity of zeaxanthin, complementary to its already known ability to inhibit PDGF-induced migration of dermal fibroblasts in the skin [15]. This value was coherent with the antiproliferative activity of the F4 fraction (34.4% ± 0.2% growth inhibition at 72 h at 100 µg·mL −1 ).…”
Section: Resultsmentioning
confidence: 96%
“…By far the main reported role for zeaxanthin in human health is in ocular health, where, together with lutein, zeaxanthin provides protection against age-related macular degeneration [ 67 , 68 ]. In addition, potential antitumor properties have been described for zeaxanthin [ 69 ]. Furthermore, it was recently found that meso-zeaxanthin has an inhibitory effect on the mutagenicity of fi ve mutagenic agents, including nitro-ophenylenediamine and N -methyl-N ′-nitro-N -nitrosoguanidine [ 70 ].…”
Section: Lutein [ β ( Beta ) ε ( Epsilon )-Carotene -3 3′ -Diol ]mentioning
confidence: 99%